profenamine has been researched along with Alzheimer Disease in 2 studies
profenamine: was heading 1972-94 (see under PHENOTHIAZINES 1972-90); use PHENOTHIAZINES to search ETHOPROPAZINE 1972-94
profenamine : A member of the class of phenothiazines that is phenothiazine in which the hydrogen attached to the nitrogen is substituted by a 2-(diethylamino)propyl group. An antimuscarinic, it is used as the hydrochloride for the symptomatic treatment of Parkinson's disease.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tasso, B | 1 |
| Catto, M | 1 |
| Nicolotti, O | 1 |
| Novelli, F | 1 |
| Tonelli, M | 1 |
| Giangreco, I | 1 |
| Pisani, L | 1 |
| Sparatore, A | 1 |
| Boido, V | 1 |
| Carotti, A | 1 |
| Sparatore, F | 1 |
| Williams, A | 1 |
| Zhou, S | 1 |
| Zhan, CG | 1 |
2 other studies available for profenamine and Alzheimer Disease
| Article | Year |
|---|---|
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cattle; Cholinesterase Inhi | 2011 |
Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Humans; Molecular Structure; Structure-Activity Relati | 2019 |